Carney rules out energy as trade leverage, Ottawa approves new nickel mine and Allied Gold’s $5.5-billion sale collapses: Must-read business and investing stories for the week of Aug. 1

Prime Minister Mark Carney said Canada will not restrict oil and gas supply to the U.S. as leverage in trade talks, while Ottawa plans to scrap a tax on online streaming services. Canada approved Canada Nickel’s Crawford nickel mine, targeting first production in 2029. Allied Gold called off its $5.5B deal with Zijin after China delayed approval; shares fell over 18% to $24. Apotex is temporarily the only generic Ozempic supplier in Canada.

Original reporting
Published Aug 1, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 1, 2026, 2:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Carney rules out energy as trade leverage, Ottawa approves new nickel mine and Allied Gold’s $5.5-billion sale collapses: Must-read business and investing stories for the week of Aug. 1 — source image
Decision brief

The 30-second read

$AGIBearishMed
01

Why it matters

For traders, the actionable items are the regulatory-driven cancellation of Allied Gold’s acquisition and the near-term Canada supply concentration for generic Ozempic under Apotex.

02

Market read

Regulatory outcomes drive immediate repricing in mining M&A and GLP-1 generic supply expectations, while the nickel approval adds a longer-dated capex catalyst.

03

What to watch

The article does not detail Allied’s breakup costs, financing status, or revised strategy, and it does not specify Apotex’s capacity limits or how quickly competitors can return to supply.

Relevance 6/10Novelty 6/10Timing: same-day deal cancellation and share plunge; near-term generic supply gap in Canada

Background

The digest covers Canadian trade policy signals, a nickel mine regulatory approval, an aborted gold acquisition, and a temporary generic Ozempic supply shift.

Company-level read

Ticker impact

$AGIBearishHigh confidence
Context

Allied Gold called off its $5.5-billion takeover of Zijin after China’s foreign investment regulator failed to approve on time, sending shares down over 18%.

Expected impact

Near-term downside bias and elevated volatility versus pre-news levels.

Evidence & confidence

The article reports the transaction is cancelled due to regulatory timing, and it cites a same-day >18% share plunge on the Toronto Stock Exchange.

Market effects

Nickel project approval supports Canadian base-metals capex sentiment; Ozempic generic supply disruption highlights GLP-1 manufacturing concentration risk.

Canada-focused catalysts across mining and pharma supply chains.

China regulatory timing affects cross-border M&A risk; GLP-1 supply constraints have broader international demand implications.

Counterpoint

Allied Gold’s cancellation may free it to pursue alternative buyers or restructure, limiting long-term damage beyond the initial selloff.

Key entities

  • Allied Gold Corp.

    Called off its $5.5-billion takeover of Zijin Gold after China’s foreign investment regulator missed the approval timeline.

  • Apotex Health Corp.

    Becomes the only maker of generic Ozempic in Canada for the next few months due to manufacturing issues at competitors.

  • Canada Nickel Co. Inc.

    Received federal approval to build the Crawford nickel mine in northern Ontario, targeting first production in 2029.

Related articles

$AGIMedAI 8/10

Alamos Gold announces second quarter results

Alamos Gold Inc. reported Q2 2026 results for the quarter ended June 30. It produced 130,600 oz of gold, up 5% QoQ, but lower than expected at Young-Davidson. Q2 revenues were $150.1M, 19% higher YoY. Full-year production guidance was cut to 100,000-115,000 oz and cost guidance raised, citing seismic damage and power outages.

$AGIMedAI 8/10

Alamos Gold Reports Second Quarter 2026 Results

Alamos Gold Inc. (TSX:AGI, NYSE:AGI) reported Q2 2026 results for the quarter ended June 30. It produced 130,600 oz of gold, with full-year production guidance lowered to 510,000 to 560,000 oz. Q2 revenues were $594.1 million, free cash flow $143.5 million, and net earnings $270.4 million. Total cash costs guidance raised to $1,175 to $1,275/oz and AISC to $1,775 to $1,875/oz.

$AGIMed

Australian Mining Company Seeks U.S. Investor to Overcome Trump-Era Sanctions on Cuban Project

Antilles Gold Limited said it is in early talks with a U.S. investment group to restructure its Cayman subsidiary Antilles Gold Inc. so a U.S.-approved investor controls at least 51%, seeking U.S. Department of State authorization to lift Trump-era sanctions on Cuba’s Minera La Victoria S.A. OFAC sanctioned MLV on June 4, 2026, disrupting projects Nueva Sabana and La Demajagua.

$AGIMed

Here is Why Alamos Gold (AGI) is One of the Most Profitable Undervalued Stocks to Invest In

Alamos Gold (NYSE:AGI) said storms and related seismic events limited access at its Young-Davidson mine, causing three days of unplanned downtime and lowering Q2 production guidance to 130,000–135,000 ounces (about 12% below prior estimates). The company expects full-year costs to exceed earlier projections. Island Gold is running at record rates, and AGI also ended remaining 2026 Argonaut hedges for $92.3 million and repurchased $30 million of shares in May.

$AGIMedAI 8/10

Alamos Gold Slides on a Young-Davidson Production Warning, Even With Bullion Near Records

Alamos Gold said its Young-Davidson mine faced seismic activity and power disruptions, cutting Q2 production to 130,000–135,000 ounces (about 12% below its prior plan midpoint) and lowering full-year output to below its 570,000–650,000 guidance, per a June 18 update. The stock fell ~18% in Toronto June 19 and ~12% in early U.S. trading June 22. BMO cut its price target to C$73 from C$79 while keeping an Outperform rating.